Premium
A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta‐blockade and steady‐state pharmacokinetics.
Author(s) -
Ishizaki T,
Oyama Y,
Suganuma T,
Sasaki T,
Nakaya H,
Shibuya T,
Sato T
Publication year - 1983
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1983.tb02138.x
Subject(s) - atenolol , plasma renin activity , blood pressure , blockade , pharmacokinetics , medicine , essential hypertension , beta (programming language) , mean blood pressure , renin–angiotensin system , pharmacology , endocrinology , heart rate , receptor , computer science , programming language
The relationship between the oral dosage and plasma concentration of the long‐acting cardioselective beta‐adrenoceptor blocker atenolol and the antihypertensive response to the the degree of beta‐adrenoceptor blockade and change in plasma renin activity (PRA) was evaluated in patients with mild‐to‐moderate essential hypertension in a double‐ blind, randomized, between‐patient, dose‐ranging (25, 50 or 100 mg once daily for 4 weeks) study. The optimum, or minimum, daily dose of atenolol to treat patients with mild‐to‐moderate hypertension was not clearly identified in this study. A between‐treatment comparison did not demonstrate that all blood pressure falls were always less in the 25 mg group than in the other two groups. Calculation of beta‐error or the power for the negative results between doses suggested that a large sample size is required to draw a conclusion that no dose‐ antihypertensive relationship of atenolol exists in the treatment of mild‐to‐moderate hypertension. A relatively flat plasma concentration‐ antihypertensive response relationship was observed. Steady‐state plasma concentrations of atenolol were dose‐related and renal drug clearance was well correlated with individual creatinine clearance. beta‐adrenoceptor blockade was better correlated with plasma atenolol concentration. Correlations which were less strong were between plasma drug concentration and change in various blood pressures and between blood pressure falls and beta‐adrenoceptor blockade. There was no relationship between the fall in blood pressure and change in PRA. Atenolol appeared to suppress PRA in an all‐or‐none fashion.